🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

What’s Moving The Markets On Monday?

Published 09/14/2020, 04:03 AM
UK100
-
MSFT
-
ORCL
-
NVDA
-
PFE
-
AZN
-

Vaccine trials restart 

Over the weekend, Oxford University announced that the joint AstraZeneca (NYSE:AZN) COVID vaccine trial will restart this week after a routine pause n the previous week. News that the trial is back on track is music to the ears of the market. A vaccine is the surest and quickest, and possibly the only way for the economy to recover to pre-pandemic growth levels. The vaccine news comes as the “Rule of 6” comes into force in the UK, banning meetings of groups of over 6. AstraZeneca shares are on the rise in early trade.  

Adding to the upbeat vaccine news Pfizer (NYSE:PFE) In Chief executive officer Albert Bourla said its likely that a COVID vaccine will be deployed in the US by the end of the year. A more optimistic view than health authorities.  

Internal Markets Bill debate 

Markets and the Pound are braced for another big Brexit week. The controversial internal markets bill will start to be discussed today in the House of Commons. It is not certain whether the bill will make it through the Commons or even the Lords given that it breaks international law. However, if it does clear Parliaments the Justice Secretary Robert Buckland has already said he will resign. The Pound was the worst performer across the previous week, shedding 3.7% versus the USD in its worst weekly performance since early March. GBP is one of the of performing majors this morning ahead of the debate. 

Whilst the 8th round of Brexit talks ended with unsurprisingly little progress, informal Brexit talks are set to continue across the week, ahead of the 9th round beginning on 25th September. 

TikTok to partner Oracle, Nvidia buys ARM 

Rumours are swirling that TiKTok is choosing to partner up with Oracle (NYSE:ORCL) rather than Microsoft (NASDAQ:MSFT). Microsoft hasn’t been asked to revise its initial offer amid opposition to the deal from the Chinese government. Has Microsoft managed to dodge a bullet? Could be so according to Bloomberg reports that the deal no longer includes key underlying technologies and the prospect of Chinese government approval is unclear at best. 

Nvidia (NASDAQ:NVDA) has agreed to buy ARM Holding, SoftBank’s chip division for $40 billion 4 years after the Japanese bank bought it for $32 billion. 

Eurozone industrial production 

Looking ahead, Eurozone industrial production data will provide some clues as to the health of the sector. Expectations are for growth 10% mom in July, up from 9.1% in June as the sector outperforms services in its recovery.  

FTSE Chart 

The FTSE is continuing its rebound from Sept 3rd lows, pishing above 50,100 and 200 sma on 4 hr chart. Immediate resistance can be seen at 6110 prior to 6180 (high 25th Aug). 

Support can be seen at 6030 200 sma, prior to 5980 (100sma). 

FTSE Chart

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.